QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report “Gelatin Haemostatic Sponge- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Gelatin Haemostatic Sponge market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Gelatin Haemostatic Sponge was estimated to be worth US$ 1150 million in 2025 and is projected to reach US$ 1501 million, growing at a CAGR of 4.2% from 2026 to 2032.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5787945/gelatin-haemostatic-sponge
Gelatin Haemostatic Sponge Market Summary
Gelatin Haemostatic Sponge is an absorbable hemostatic medical consumable made of high-purity gelatin, used to promote clotting and achieve local hemostasis at surgical or traumatic bleeding sites. The porous sponge structure absorbs blood and concentrates platelets and clotting factors, creating a physical matrix that accelerates hemostasis. These sponges can be cut to shape and used alone or combined with thrombin depending on bleeding severity. They are widely used in general surgery, orthopedics, neurosurgery, ENT, and dental procedures. Key performance requirements include rapid absorption, predictable biodegradation, biocompatibility, sterility assurance, and consistent pore structure to balance swelling and hemostatic efficacy. The industrial chain of Gelatin Haemostatic Sponges includes upstream inputs such as medical-grade gelatin raw material, purification reagents, water for injection, sterilization supplies, packaging films, and labeling materials. Midstream manufacturing covers gelatin solution preparation, foaming or freeze-drying to create porous structure, molding/cutting, drying, sterilization (e.g., gamma or EO), and quality testing for absorbency, endotoxin, bioburden, and mechanical integrity. Downstream users include hospitals, surgical centers, trauma care units, and medical distributors. Services include clinical training, regulatory compliance support, post-market surveillance, and supply chain assurance for sterile medical products.
Upstream (Raw Materials and Key Elements)
Centered on animal-derived medical-grade gelatin/collagen (commonly from pigs and cattle), upstream value primarily stems from “purification and safety control” (endotoxins, microorganisms, residues, batch consistency) and raw material traceability and compliance certification. Supporting components include sterilization packaging materials, clean production consumables, and testing services. Upstream fluctuations and regulatory/religious compliance requirements directly impact costs, supply stability, and registration strategies.
Midstream (Manufacturing and Branding)
The midstream process transforms medical-grade gelatin into gelatin hemostatic sponges of various specifications through processes such as foaming, molding, freeze-drying, cutting, packaging, sterilization, and aseptic packaging. Core barriers lie in pore structure consistency, post-sterilization performance retention, batch-to-batch stability, and yield control. Industry competition is shifting from “single sponge blocks” to “specialized specifications/kits (easier to handle, adaptable to complex bleeding points).” The midstream leverages process stability and clinical user experience to achieve premium pricing and economies of scale.
Downstream (Channels and Application Scenarios)
The downstream market primarily targets hospital surgical departments (general surgery, orthopedics, neurosurgery, cardiothoracic surgery, hepatobiliary and pancreatic surgery, obstetrics and gynecology, etc.) and dental clinics, entering clinical pathways through distribution/centralized procurement/hospital access. The procurement side is increasingly emphasizing supply stability, intraoperative efficiency, and overall costs (operative time, rework, complication risks), requiring companies to use clinical evidence and standardized operating procedures to drive replacement and volume increases, in addition to price.
Prices for gelatin haemostatic sponges vary widely by brand tier, sponge format (sheet vs. dental cubes), sterility/pack configuration, and the procurement channel (hospital contract vs. retail). The gross profit margin of major companies in the industry is between 10%–30%. According to the new market research report “Global Gelatin Haemostatic Sponge Market Report 2026-2032”, published by QYResearch, the global Gelatin Haemostatic Sponge market size is projected to reach USD 1.5 billion by 2032, at a CAGR of 4.2% during the forecast period.
Global Gelatin Haemostatic Sponge Market Size (US$ Million), 2020-2031
Above data is based on report from QYResearch: Global Gelatin Haemostatic Sponge Market Report 2021-2032 (published in 2025). If you need the latest data, plaese contact QYResearch.
Global Gelatin Haemostatic Sponge Top 10 Players Ranking and Market Share (Ranking is based on the revenue of 2025, continually updated)
Above data is based on report from QYResearch: Global Gelatin Haemostatic Sponge Market Report 2026-2032 (published in 2025). If you need the latest data, plaese contact QYResearch.
According to QYResearch Top Players Research Center, the global key manufacturers of Gelatin Haemostatic Sponge include Pfizer, Johnson & Johnson, B. Braun, Gelita Medical, Cura Medical, Aegis Lifesciences, COLTENE, Dispotech, EUCARE Pharmaceuticals, BOENMED, etc. In 2025, the global top 10 players had a share approximately 65.0% in terms of revenue.
Gelatin Haemostatic Sponge Industry Development Trends
1) Demand Side: Expanding Surgical Volume and the “Anticoagulant Population” Makes Local Hemostasis Standard. The penetration of local hemostatic materials continues to increase in general surgery, orthopedics, neurosurgery, dentistry, and trauma settings. Postoperative bleeding in the oral cavity is more common in patients undergoing anticoagulation/antiplatelet therapy, driving the standardization of “ready-to-use local hemostatic materials.”
2) Product Form Upgrade: From “Sponge Blocks” to “Injectable/Moldable Flowable Matrix”. In expert consensus and clinical discussions, flowable gelatin + thrombin is considered more suitable for scenarios with “difficult-to-reach, irregular shapes, and continuous oozing” (typically tumor resection, transsphenoidal procedures, and deep cavities).
3) “Combination” Becomes a Profit Driver: Gelatin × Thrombin / Antibacterial / Regenerative Functional Integration. Gelatin sponges are easier to standardize and domestically produce, with premium pricing increasingly relying on combination solutions (e.g., forming a stronger hemostatic matrix with thrombin).
4) Scenario Expansion: Dental/oral surgery and minimally invasive day surgery bring stable growth. Oral surgery relies heavily on local hemostatic materials; brands are also continuously launching new models/series of products in the dental channel (reflecting the trend of “productization of segmented scenarios”).
Restraint in the Gelatin Haemostatic Sponge Industry
1）Clinical safety boundaries limit use-cases
Labels typically warn against intravascular use due to embolization risk and include other contraindications/precautions, which narrows indications and increases training/IFU compliance burden.
2）Sterilization dependence and EtO compliance pressure
Many absorbable hemostats rely on ethylene oxide (EtO) sterilization; tighter regulatory scrutiny, residue limits, and process/QMS expectations raise cost and qualification timelines (and can force revalidation).
3）Animal-derived raw material constraints
Being typically porcine/bovine-derived, the category faces tighter expectations on traceability, bioburden/endotoxin control, and—commercially—religious/cultural acceptance and tender exclusions in some markets (often requiring portfolio redundancy).
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The Gelatin Haemostatic Sponge market is segmented as below:
By Company
Pfizer
Johnson & Johnson
B. Braun
Gelita Medical
Cura Medical
Aegis Lifesciences
COLTENE
Dispotech
Ferrosan Medical Devices
EUCARE Pharmaceuticals
BOENMED
Medelast
JIAXING KENYUE
Medzeel Lifescience
Goodwill Lifesciences
Equimedical
Healthium Medtech
Septodont
Assut Europe
Nanchang Hushida Medical Technology
Segment by Type
Porcine Gelatin Sponge
Cow Gelatin Sponge
Others
Segment by Application
Hospital
Clinic
Others
Each chapter of the report provides detailed information for readers to further understand the Gelatin Haemostatic Sponge market:
Chapter 1: Introduces the report scope of the Gelatin Haemostatic Sponge report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of Gelatin Haemostatic Sponge manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various Gelatin Haemostatic Sponge market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of Gelatin Haemostatic Sponge in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of Gelatin Haemostatic Sponge in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth Gelatin Haemostatic Sponge competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.
Industry Analysis: QYResearch provides Gelatin Haemostatic Sponge comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.
and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.
Market Size: QYResearch provides Gelatin Haemostatic Sponge market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.
Other relevant reports of QYResearch:
Global Gelatin Haemostatic Sponge Market Research Report 2026
Global Gelatin Haemostatic Sponge Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Gelatin Haemostatic Sponge Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Animal-base Gelatin Haemostatic Sponge Market Research Report 2026
Animal-base Gelatin Haemostatic Sponge- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Global Animal-base Gelatin Haemostatic Sponge Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Animal-base Gelatin Haemostatic Sponge Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
